Ghent University Academic Bibliography

Advanced

Pilot study of mobile phone technology in allergic rhinitis in European countries : the MASK-rhinitis study

J Bousquet, DP Caimmi, A Bedbrook, M Bewick, PW Hellings, P Devillier, S Arnavielhe, Claus Bachert UGent, KC Bergmann, GW Canonica, et al. (2017) ALLERGY. 72(6). p.857-865
abstract
Background: The use of Apps running on smartphones and tablets profoundly affects medicine. The MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) App (Allergy Diary) assesses allergic rhinitis symptoms, disease control and impact on patients' lives. It is freely available in 20 countries (iOS and Android platforms). Aims: To assess in a pilot study whether (i) Allergy Diary users were able to properly provide baseline characteristics (ii) simple phenotypic characteristics based upon data captured by the Allergy Diary could be identified and (iii) information gathered by this study could suggest novel research questions. Methods: The Allergy Diary users were classified into six groups according to the baseline data that they entered into the App: (i) asymptomatic; (ii) nasal symptoms excluding rhinorrhea; (iii) rhinorrhea; (iv) rhinorrhea plus 1-2 nasal/ocular symptoms; (v) rhinorrhea plus >= 3 nasal/ocular symptoms; and (vi) rhinorrhea plus all nasal/ocular symptoms. Results: By 1 June 2016, 3260 users had registered with the Allergy Diary and 2710 had completed the baseline questionnaire. Troublesome symptoms were found mainly in the users with the most symptoms. Around 50% of users with troublesome rhinitis and/or ocular symptoms suffered work impairment. Sleep was impaired by troublesome symptoms and nasal obstruction. Conclusions: This is the first App (iOS and Android) to have tested for allergic rhinitis and conjunctivitis. A simple questionnaire administered by cell phones enables the identification of phenotypic differences between a priori defined rhinitis groups. The results suggest novel concepts and research questions in allergic rhinitis that may not be identified using classical methods.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (review)
publication status
published
subject
keyword
allergen immunotherapy, Allergy Diary, EIP on AHA, MASK-rhinitis, mobile technology, QUALITY-OF-LIFE, PRIMARY-CARE, IMPACT, ASTHMA, SEVERITY, SYMPTOMS, MEDICINE, DISEASES, ADULTS, TRIAL
journal title
ALLERGY
Allergy
volume
72
issue
6
pages
857 - 865
Web of Science type
Review
Web of Science id
000402834300004
ISSN
0105-4538
DOI
10.1111/all.13125
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
8513668
handle
http://hdl.handle.net/1854/LU-8513668
date created
2017-03-09 15:26:35
date last changed
2017-09-06 14:03:38
@article{8513668,
  abstract     = {Background: The use of Apps running on smartphones and tablets profoundly affects medicine. The MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) App (Allergy Diary) assesses allergic rhinitis symptoms, disease control and impact on patients' lives. It is freely available in 20 countries (iOS and Android platforms). 
Aims: To assess in a pilot study whether (i) Allergy Diary users were able to properly provide baseline characteristics (ii) simple phenotypic characteristics based upon data captured by the Allergy Diary could be identified and (iii) information gathered by this study could suggest novel research questions. 
Methods: The Allergy Diary users were classified into six groups according to the baseline data that they entered into the App: (i) asymptomatic; (ii) nasal symptoms excluding rhinorrhea; (iii) rhinorrhea; (iv) rhinorrhea plus 1-2 nasal/ocular symptoms; (v) rhinorrhea plus {\textrangle}= 3 nasal/ocular symptoms; and (vi) rhinorrhea plus all nasal/ocular symptoms. 
Results: By 1 June 2016, 3260 users had registered with the Allergy Diary and 2710 had completed the baseline questionnaire. Troublesome symptoms were found mainly in the users with the most symptoms. Around 50\% of users with troublesome rhinitis and/or ocular symptoms suffered work impairment. Sleep was impaired by troublesome symptoms and nasal obstruction. 
Conclusions: This is the first App (iOS and Android) to have tested for allergic rhinitis and conjunctivitis. A simple questionnaire administered by cell phones enables the identification of phenotypic differences between a priori defined rhinitis groups. The results suggest novel concepts and research questions in allergic rhinitis that may not be identified using classical methods.},
  author       = {Bousquet, J and Caimmi, DP and Bedbrook, A and Bewick, M and Hellings, PW and Devillier, P and Arnavielhe, S and Bachert, Claus and Bergmann, KC and Canonica, GW and Chavannes, NH and Cruz, AA and Dahl, R and Demoly, P and De Vries, G and Mathieu-Dupas, E and Finkwagner, A and Fonseca, J and Guldemond, N and Haahtela, T and Hellqvist-Dahl, B and Just, J and Keil, T and Klimek, L and Kowalski, ML and Kuitunen, M and Kuna, P and Kvedariene, V and Laune, D and Pereira, AM and Carreiro-Martins, P and Mel{\'e}n, E and Morais-Almeida, M and Mullol, J and Muraro, A and Murray, R and Nogueira-Silva, L and Papadopoulos, NG and Passalacqua, G and Portejoie, F and Price, D and Ryan, D and Samolinski, B and Sheikh, A and Siroux, V and Spranger, O and Todo Bom, A and Tomazic, PV and Valero, A and Valovirta, E and Valiulis, A and VandenPlas, O and van der Meulen, S and van Eerd, M and Wickman, M and Zuberbier, T},
  issn         = {0105-4538},
  journal      = {ALLERGY},
  keyword      = {allergen immunotherapy,Allergy Diary,EIP on AHA,MASK-rhinitis,mobile technology,QUALITY-OF-LIFE,PRIMARY-CARE,IMPACT,ASTHMA,SEVERITY,SYMPTOMS,MEDICINE,DISEASES,ADULTS,TRIAL},
  language     = {eng},
  number       = {6},
  pages        = {857--865},
  title        = {Pilot study of mobile phone technology in allergic rhinitis in European countries : the MASK-rhinitis study},
  url          = {http://dx.doi.org/10.1111/all.13125},
  volume       = {72},
  year         = {2017},
}

Chicago
Bousquet, J, DP Caimmi, A Bedbrook, M Bewick, PW Hellings, P Devillier, S Arnavielhe, et al. 2017. “Pilot Study of Mobile Phone Technology in Allergic Rhinitis in European Countries : the MASK-rhinitis Study.” Allergy 72 (6): 857–865.
APA
Bousquet, J, Caimmi, D., Bedbrook, A., Bewick, M., Hellings, P., Devillier, P., Arnavielhe, S., et al. (2017). Pilot study of mobile phone technology in allergic rhinitis in European countries : the MASK-rhinitis study. ALLERGY, 72(6), 857–865.
Vancouver
1.
Bousquet J, Caimmi D, Bedbrook A, Bewick M, Hellings P, Devillier P, et al. Pilot study of mobile phone technology in allergic rhinitis in European countries : the MASK-rhinitis study. ALLERGY. 2017;72(6):857–65.
MLA
Bousquet, J, DP Caimmi, A Bedbrook, et al. “Pilot Study of Mobile Phone Technology in Allergic Rhinitis in European Countries : the MASK-rhinitis Study.” ALLERGY 72.6 (2017): 857–865. Print.